Research Topics
Genomes and Genes
| P M ComoglioSummaryAffiliation: University of Turin Country: Italy Publications
| Collaborators
|
Detail Information
Publications
Plasminogen-related growth factor and semaphorin receptors: a gene superfamily controlling invasive growthP M Comoglio
Institute for Cancer Research and Treatment, University of Turin School of Medicine, Candiolo, 10060, Italy
Exp Cell Res 253:88-99. 1999..Deregulated activation of PRGF or semaphorin ligands or receptors, by mutation or overexpression, confers to cancer cells invasive and metastatic properties...
Scatter factors and invasive growthP M Comoglio
Division of Molecular Oncology, IRCC, Institute for Cancer Research, Str Provinciale 142, Km 3 95, Candiolo TO, 10060, Italy
Semin Cancer Biol 11:153-65. 2001..Here we discuss how alterations of these receptors or of their signal transduction pathways are responsible for cancer onset and progression towards metastasis...
Invasive growth: from development to metastasisPaolo M Comoglio
Division of Molecular Oncology, Institute for Cancer Research and Treatment, University of Torino School of Medicine, Candiolo (Torino, Italy
J Clin Invest 109:857-62. 2002
Uncoupling signal transducers from oncogenic MET mutants abrogates cell transformation and inhibits invasive growthA Bardelli
Institute for Cancer Research and Treatment, University of Torino, School of Medicine 10060, Candiolo, Italy
Proc Natl Acad Sci U S A 95:14379-83. 1998....
HGF/scatter factor selectively promotes cell invasion by increasing integrin avidityL Trusolino
Institute for Cancer Research and Treatment, University of Torino Medical School, 10060 Candiolo Torino, Italy
FASEB J 14:1629-40. 2000..These data suggest that HGF/SF promotes cell adhesion and invasiveness by increasing the avidity of integrins for their specific ligands...
Cross-talk between the proto-oncogenes Met and RonA Follenzi
Institute for Cancer Research and Treatment IRCC, University of Torino, School of Medicine 10060, Candiolo, Italy
Oncogene 19:3041-9. 2000..These data show that, while specific for their ligands, scatter factor receptors cross-talk and cooperate in intracellular signaling...
Interactions between scatter factors and their receptors: hints for therapeutic applicationsL Trusolino
Division of Molecular Oncology, IRCC, Institute for Cancer Research, University of Torino School of Medicine, 10060 Candiolo, Torino
FASEB J 12:1267-80. 1998..This review is focused on how, and to what extent, scatter factors can behave 'well' or 'badly' according to their molecular structure, the way they are activated, and the way they interact with cell surface receptors and coreceptors...
A point mutation in the MET oncogene abrogates metastasis without affecting transformationS Giordano
Institute for Cancer Research, University of Torino Medical School, Strada Provinciale 142, Km 3 95, 10060 Candiolo, Italy
Proc Natl Acad Sci U S A 94:13868-72. 1997....
Induction of epithelial tubules by growth factor HGF depends on the STAT pathwayC Boccaccio
Institute for Cancer Research, University of Torino Medical School, Candiolo, Italy
Nature 391:285-8. 1998..Activation of signal transducers that directly control transcription is therefore required for morphogenesis...
Plexin signaling hampers integrin-based adhesion, leading to Rho-kinase independent cell rounding, and inhibiting lamellipodia extension and cell motilityD Barberis
Institute for Cancer Research and Treatment, University of Torino School of Medicine, Candiolo, Italy
FASEB J 18:592-4. 2004..We conclude that plexin signaling uncouples cell substrate-adhesion from cytoskeletal dynamics required for cell migration and axon extension...
A signaling adapter function for alpha6beta4 integrin in the control of HGF-dependent invasive growthL Trusolino
IRCC, Institute for Cancer Research and Treatment, University of Torino School of Medicine, 10060 Torino, Candiolo, Italy
Cell 107:643-54. 2001..Such findings invoke an unexpected role for alpha6beta4 in cancer invasion as a functional amplifier of biochemical outputs rather than a mechanical adhesive device...
Met-driven invasive growth involves transcriptional regulation of Arhgap12A Gentile
Laboratory of Functional Genomics, The Oncogenomics Center, Institute for Cancer Research and Treatment, University of Turin Medical School, Turin, Italy
Oncogene 27:5590-8. 2008..Consistently, Arhgap12 silencing by RNA interference selectively increased the scatter and adhesion responses. These data show that HGF-driven invasive growth involves transcriptional regulation of a Rac1-specific GAP...
Ligand-regulated binding of FAP68 to the hepatocyte growth factor receptorS Grisendi
Institute for Cancer Research and Treatment, University of Turin 10060, Candiolo, Italy
J Biol Chem 276:46632-8. 2001..Significantly, nonphosphorylated HGF receptor prevents FAP68 from stimulating p70S6K. These data suggest a role for FAP68 in coupling HGF receptor signaling to the p70S6K pathway...
Agonistic monoclonal antibodies against the Met receptor dissect the biological responses to HGFM Prat
Institute for Cancer Research IRCC, University of Torino, Medical School, Candiolo, Italy
J Cell Sci 111:237-47. 1998..Since simple receptor dimerization is not sufficient to trigger full biological responses, we propose that the region on the ss chain of the receptor recognized by the full agonist mAb is crucial for optimal receptor activation...
Macrophage stimulating protein is a novel neurotrophic factorM C Stella
Institute for Cancer Research and Treatment, IRCC, University of Torino Medical School, 10060 Candiolo, Torino, Italy
Mol Biol Cell 12:1341-52. 2001..Together, these data suggest that MSP is a novel neurotrophic factor for cranial motoneurons and, by regulating the production of NO, may have a role in brain plasticity and regeneration...
Silencing the MET oncogene leads to regression of experimental tumors and metastasesS Corso
Division of Molecular Oncology, Institute for Cancer Research and Treatment IRCC, University of Turin Medical School, Candiolo, Torino, Italy
Oncogene 27:684-93. 2008..Notably, silencing MET in already established metastases led to their almost complete regression. This indicates that persistent expression of the MET oncogene is mandatory until the advanced phases of cancer progression...
A gene trap vector system for identifying transcriptionally responsive genesE Medico
Institute for Cancer Research and Treatment, University of Torino School of Medicine, 10060 Candiolo, Italy
Nat Biotechnol 19:579-82. 2001..The flexibility and efficiency of the GFNR-based trap screening procedure make it suitable for wide surveys of transcriptionally regulated genes...
Osteopontin is an autocrine mediator of hepatocyte growth factor-induced invasive growthE Medico
Institute for Cancer Research and Treatment, University of Torino School of Medicine, 10060 Candiolo To, Italy
Cancer Res 61:5861-8. 2001....
HGF: a multifunctional growth factor controlling cell scatteringM C Stella
Institute for Cancer Research I R C C, University of Torino Medical School, Candiolo, Torino, Italy
Int J Biochem Cell Biol 31:1357-62. 1999..The role of HGF as putative therapeutical agent in pathologies characterized by massive cell loss or deregulated cell proliferation is under investigation...
Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebratesL Tamagnone
Institute for Cancer Research and Treatment, University of Torino, Candiolo, Italy
Cell 99:71-80. 1999..We conclude that plexins are receptors for multiple (and perhaps all) classes of semaphorins, either alone or in combination with neuropilins, and trigger a novel signal transduction pathway controlling cell repulsion...
Sustained recruitment of phospholipase C-gamma to Gab1 is required for HGF-induced branching tubulogenesisP Gual
Institute for Cancer Research and Treatment IRCC, University of Torino Medical School, Str Prov 142, Km 3 95, 10060 Candiolo, Italy
Oncogene 19:1509-18. 2000..It is concluded that sustained recruitment of PLCgamma to Gab1 plays an important role in branching tubulogenesis...
A splicing variant of the RON transcript induces constitutive tyrosine kinase activity and an invasive phenotypeC Collesi
Institute for Cancer Research, University of Turin Medical School, Italy
Mol Cell Biol 16:5518-26. 1996..These data (i) provide a novel molecular mechanism for posttranscriptional activation of a tyrosine kinase receptor protein and (ii) suggest a role for the Ron receptor in progression toward malignancy...
Receptor tyrosine kinases as therapeutic targets: the model of the MET oncogeneP Longati
Institute for Cancer Research, University of Torino Medical School, Candiolo, Italy
Curr Drug Targets 2:41-55. 2001..By using the MET oncogene as a model this review focuses on the strategies that can be applied to therapeutically target RTKs...
"Invasive-growth" signaling by the Met/HGF receptor: the hereditary renal carcinoma connectionA Bardelli
Institute for Cancer Research (IRCC, University of Torino Medical School, Candiolo, Turin, Italy
Biochim Biophys Acta 1333:M41-51. 1997
Staging of head and neck squamous cell carcinoma using the MET oncogene product as marker of tumor cells in lymph node metastasesG Cortesina
Department of Clinical Physiopathology, University of Torino School of Medicine, Torino, Italy
Int J Cancer 89:286-92. 2000..After RT-PCR analysis we were able to attribute a more advanced stage to 10 out of 20 HNSCC cases, including 5 cases classified as tumor-free after routine histopathology...
Apoptosis enhancement by the HIV-1 Nef proteinA Rasola
Division of Molecular Oncology, Institute for Cancer Research, University of Torino Medical School, Candiolo, Italy
J Immunol 166:81-8. 2001..These data show that Nef enhances programmed cell death in different cell types by affecting multiple critical components of the apoptotic machinery independently from the Fas pathway...
HGF receptor associates with the anti-apoptotic protein BAG-1 and prevents cell deathA Bardelli
Institute for Cancer Research I R C C, University of Torino School of Medicine, Italy
EMBO J 15:6205-12. 1996..The finding of a link between growth factor receptors and the anti-apoptotic machinery fills a gap in the understanding of the molecular events regulating programmed cell death...
The proto-oncogene RON is involved in development of epithelial, bone and neuro-endocrine tissuesG Gaudino
Institute for Cancer Research I R C C, University of Torino School of Medicine, Italy
Oncogene 11:2627-37. 1995..These findings show that the Ron receptor and its ligand are involved in the development of epithelial tissues, bones, and neuroendocrine derivatives driving cells towards the proliferation program...
Invasive growth: a two-way street for semaphorin signallingPaolo M Comoglio
Nat Cell Biol 6:1155-7. 2004
The MET oncogene drives a genetic programme linking cancer to haemostasisCarla Boccaccio
Division of Molecular Oncology, Institute for Cancer Research and Treatment, University of Turin Medical School, Str Prov 142, I 10060 Candiolo, Torino, Italy
Nature 434:396-400. 2005..In vivo analysis showed that both proteins support the thrombohaemorrhagic phenotype, thus providing direct genetic evidence for the long-sought-after link between oncogene activation and haemostasis...
Negative feedback regulation of Met-dependent invasive growth by NotchM Cristina Stella
Institute for Cancer Research and Treatment, University of Turin School of Medicine, Division of Molecular Oncology, IV Floor, Str Prov 142, km 3, 95, 10060 Candiolo, Torino, Italy
Mol Cell Biol 25:3982-96. 2005..These results unravel an in-built mechanism of negative feedback regulation in which Met activation leads to transcriptional induction of Notch function, which in turn limits HGF activity through repression of the Met oncogene...
An uncleavable form of pro-scatter factor suppresses tumor growth and dissemination in miceMassimiliano Mazzone
Division of Molecular Oncology, Institute for Cancer Research and Treatment, University of Torino Medical School, Candiolo, Italy
J Clin Invest 114:1418-32. 2004..These data show that proteolytic activation of pro-SF is a limiting step in tumor progression, thus suggesting a new strategy for the treatment or prevention of the malignant conversion of neoplastic lesions...
Invasive growth: a MET-driven genetic programme for cancer and stem cellsCarla Boccaccio
Institute for Cancer Research and Treatment IRCC, University of Turin Medical School, Str Prov 142, 10060 Candiolo, Italy
Nat Rev Cancer 6:637-45. 2006....
Cancer therapy: can the challenge be MET?Simona Corso
IRCC, Institute for Cancer Research and Treatment, University of Turin School of Medicine, Division of Molecular Oncology, 10060 Candiolo, Turin, Italy
Trends Mol Med 11:284-92. 2005..Interfering with Met activation is thus a new and challenging approach to hamper tumorigenic and metastatic processes...
p190 Rho-GTPase activating protein associates with plexins and it is required for semaphorin signallingDavide Barberis
Institute for Cancer Research and Treatment IRCC, University of Turin Medical School, Candiolo, Torino 10060, Italy
J Cell Sci 118:4689-700. 2005..We conclude that p190-RhoGAP is crucially involved in semaphorin signalling to the actin cytoskeleton, via interaction with plexins...
A functional role for hemostasis in early cancer developmentCarla Boccaccio
Division of Molecular Oncology, Institute for Cancer Research and Treatment IRCC, University of Turin Medical School, Turino, Italy
Cancer Res 65:8579-82. 2005..These findings reveal a long-sought mechanistic link between coagulation and cancer, highlighting a clinically important perspective on malignant invasion and metastasis...
Ab-induced ectodomain shedding mediates hepatocyte growth factor receptor down-regulation and hampers biological activityAnnalisa Petrelli
Division of Molecular Oncology, Institute for Cancer Research and Treatment IRCC, University of Turin Medical School, 10060 Candiolo, Italy
Proc Natl Acad Sci U S A 103:5090-5. 2006..Interestingly, the "decoy effect" generated by the shed ectodomain, acting as a dominant negative molecule, enhanced the inhibitory effect of the Ab...
The Met pathway: master switch and drug target in cancer progressionMassimiliano Mazzone
Division of Molecular Oncology, Institute for Cancer Research and Treatment IRCC, University of Torino Medical School, Strada Provinciale 142, Km 3 95, I 10060 Candiolo Torino, Italy
FASEB J 20:1611-21. 2006..As we suggest possible directions for drug development, we propose the receptor for the hepatocyte growth factor, Met, as an ideal target for tackling cancer progression...
Drug development of MET inhibitors: targeting oncogene addiction and expediencePaolo M Comoglio
Division of Molecular Oncology, Institute for Cancer Research and Treatment IRCC, University of Turin School of Medicine, Candiolo, Turin 10060, Italy
Nat Rev Drug Discov 7:504-16. 2008..Here we discuss recent progress in the development of molecules that inhibit MET function and consider their application in a subset of human tumours that are potentially responsive to MET-targeted therapies...
The MET receptor tyrosine kinase in invasion and metastasisSilvia Benvenuti
Division of Molecular Oncology, Institute for Cancer Research and Treatment IRCC, University of Turin Medical School, Candiolo Torino, Italy
J Cell Physiol 213:316-25. 2007..Among those soluble factors a major position is exerted by hepatocyte growth factor (HGF) together with its receptor MET and macrophage-stimulating protein (MSP) in cooperation with its receptor RON...
The Met tyrosine kinase receptor in development and cancerAlessandra Gentile
Division of Molecular Oncology, University of Turin Medical School, 10060, Candiolo Torino, Italy
Cancer Metastasis Rev 27:85-94. 2008..Several approaches have been recently developed to interfere with the tumorigenic and metastatic processes triggered by Met...
The tumor suppressor semaphorin 3B triggers a prometastatic program mediated by interleukin 8 and the tumor microenvironmentCharlotte Rolny
Institute for Cancer Research and Treatment IRCC, University of Turin, School of Medicine, 10060 Candiolo, Italy
J Exp Med 205:1155-71. 2008..In conclusion, we report that SEMA3B exerts unexpected functions in cancer progression by fostering a prometastatic environment through elevated IL-8 secretion and recruitment of macrophages coupled to the suppression of tumor growth...
A high affinity hepatocyte growth factor-binding site in the immunoglobulin-like region of MetCristina Basilico
Division of Molecular Oncology, Institute for Cancer Research and Treatment, University of Turin Medical School, I 10060 Candiolo, Turin, Italy
J Biol Chem 283:21267-77. 2008..Although the IPT-HGF-alpha interaction provides binding strength, the Sema-HGF-beta contact confers selective sensitivity to the active form of the ligand...
Metron factor-1 prevents liver injury without promoting tumor growth and metastasisTerumi Takahara
Third Department of Internal Medicine, Faculty of Medicine, University of Toyama, Toyama, Japan
Hepatology 47:2010-25. 2008..CONCLUSION: These data suggest that MF-1 is as effective as HGF at preventing liver injury and at promoting hepatocyte regeneration, but therapeutically safer than HGF because it lacks proangiogenic and prometastatic activity...
Invasive growth: a genetic programAlessandra Gentile
IRCC, Institute for Cancer Research and Treatment, University of Torino School of Medicine, 10060 Candiolo, Torino, Italy
Int J Dev Biol 48:451-6. 2004..Here we discuss the different biological facets of invasive growth and analyze the intracellular signals which lead to its execution...
Truncated RON tyrosine kinase drives tumor cell progression and abrogates cell-cell adhesion through E-cadherin transcriptional repressionChiara Bardella
Laboratory of Cancer Genetics, Institute for Cancer Research and Treatment, University of Torino Medical School, 10060 Candiolo, Turin, Italy
Cancer Res 64:5154-61. 2004..Altogether, these data show that expression of a naturally occurring, constitutively active truncated RON kinase results in loss of epithelial phenotype and aggressive behavior and, thus, it might contribute to tumor progression...
Targeting the tumor and its microenvironment by a dual-function decoy Met receptorPaolo Michieli
Division of Molecular Oncology, Institute for Cancer Research and Treatment IRCC, University of Torino Medical School, I 10060 Candiolo Torino, Italy
Cancer Cell 6:61-73. 2004....
Novel somatic mutations of the MET oncogene in human carcinoma metastases activating cell motility and invasionAnnalisa Lorenzato
Laboratory of Cancer Genetics, Institute for Cancer Research and Treatment, Torino, Italy
Cancer Res 62:7025-30. 2002..These data suggest that MET might be one of the long sought oncogenes controlling progression of primary cancers to metastasis...
Functional regulation of semaphorin receptors by proprotein convertasesStefania Artigiani
Institute for Cancer Research and Treatment IRCC, University of Torino School of Medicine, 10060 Candiolo, Italy
J Biol Chem 278:10094-101. 2003..Thus, we conclude that cleavage by proprotein convertases is a novel regulatory step for semaphorin receptors localized at the cell surface...
Hypoxia promotes invasive growth by transcriptional activation of the met protooncogeneSelma Pennacchietti
Division of Molecular Oncology, Institute for Cancer Research and Treatment, University of Torino Medical School, Candiolo, Italy
Cancer Cell 3:347-61. 2003..These data show that hypoxia promotes tumor invasion by sensitizing cells to HGF stimulation, providing a molecular basis to explain Met overexpression in cancer...
Mutations in the met oncogene unveil a "dual switch" mechanism controlling tyrosine kinase activityFederica Chiara
Division of Molecular Oncology, Institute for Cancer Research and Treatment IRCC, University of Torino Medical School, I 10060 Candiolo, Torino, Italy
J Biol Chem 278:29352-8. 2003..This explains why mutant met provides an oncogenic predisposition but needs a second activating "hit," provided by sustained ligand stimulation or receptor overexpression, to achieve a fully transformed phenotype...
Scatter-factor and semaphorin receptors: cell signalling for invasive growthLivio Trusolino
Institute for Cancer Research and Treatment, University of Torino School of Medicine, Candiolo, Italy
Nat Rev Cancer 2:289-300. 2002..What are the differences between physiological and pathological activation of these signalling molecules, and can we exploit them therapeutically to prevent metastasis?..
The RON and MET oncogenes are co-expressed in human ovarian carcinomas and cooperate in activating invasivenessPiera Maggiora
Laboratory of Cancer Genetics of the Institute for Cancer Research and Treatment, University of Torino School of Medicine, SP 142, Km 3 95, 10060 Candiolo Torino, Italy
Exp Cell Res 288:382-9. 2003..These data suggest that coexpression of the MET and RON receptors confer a selective advantage to ovarian cancer cells and might promote ovarian cancer progression...
An HGF-MSP chimera disassociates the trophic properties of scatter factors from their pro-invasive activityPaolo Michieli
Division of Molecular Oncology, Institute for Cancer Research and Treatment IRCC, University of Torino Medical School, I 10060 Candiolo, Torino, Italy
Nat Biotechnol 20:488-95. 2002..In an in vivo murine model of drug-induced nephrotoxicity, intravenous injection of recombinant Metron factor 1 prevented renal damage and preserved tubular integrity...
The semaphorin 4D receptor controls invasive growth by coupling with MetSilvia Giordano
Institute for Cancer Research and Treatment, University of Torino School of Medicine, 10060 Candiolo, Torino, Italy
Nat Cell Biol 4:720-4. 2002..This work identifies a novel biological function of semaphorins and suggests the involvement of an unexpected signalling mechanism, namely, the coupling of a plexin to a tyrosine kinase receptor...
The endophilin-CIN85-Cbl complex mediates ligand-dependent downregulation of c-MetAnnalisa Petrelli
CNR CIOS and Department of Genetics, Biology and Biochemistry, University of Torino, 10126 Torino, Italy
Nature 416:187-90. 2002..These data provide further evidence of a relationship between receptor-mediated signalling and endocytosis, and disclose a novel functional role for Cbl in HGF receptor signalling...
Interactions between growth factor receptors and adhesion molecules: breaking the rulesPaolo M Comoglio
Institute for Cancer Research and Treatment, University of Torino School of Medicine, Strada Provinciale 142, 10060 Candiolo Torino, Italy
Curr Opin Cell Biol 15:565-71. 2003....
Hepatocyte growth factor and its receptor are required for malaria infectionMargarida Carrolo
, Rua da Quinta Grande 6, 2780-156 Oeiras, Portugal
Nat Med 9:1363-9. 2003..Our findings identify HGF and MET as potential targets for new approaches to malaria prevention...
Tyrosine kinase signal specificity: lessons from the HGF receptorAndrea Bertotti
IRCC, Institute for Cancer Research and Treatment, University of Torino School of Medicine, 10060, Candiolo (Torino, Italy
Trends Biochem Sci 28:527-33. 2003..This suggests that integration of cell-restricted expression of receptor partners that modulate kinase outputs with the intrinsic signalling features of receptors is required for specification of biological responses...
A differentiation switch for genetically modified hepatocytesCarla Boccaccio
Institute for Cancer Research and Treatment, University of Torino Medical School, 10060 Candiolo Torino, Italy
FASEB J 16:120-2. 2002....
To move or not to move? Semaphorin signalling in cell migrationLuca Tamagnone
Institute for Cancer Research and Treatment, University of Turin Medical School IRCC, SP 142, 10060 Candiolo, Turin, Italy
EMBO Rep 5:356-61. 2004..This review focuses on the mechanisms whereby semaphorins are thought to regulate cell migration...
Reactive oxygen species mediate Met receptor transactivation by G protein-coupled receptors and the epidermal growth factor receptor in human carcinoma cellsOliver M Fischer
Department of Molecular Biology, Max Planck Institute of Biochemistry, Am Klopferspitz 18a, D 82152 Martinsried, Germany
J Biol Chem 279:28970-8. 2004....
Plexin-B3 is a functional receptor for semaphorin 5AStefania Artigiani
Institute for Cancer Research and Treatment IRCC, University of Torino Medical School, 10060 Candiolo To, Italy
EMBO Rep 5:710-4. 2004..We thus conclude that Sema5A is able to elicit multiple functional responses through its receptor plexin-B3...
Feline STK gene expression in mammary carcinomasRaffaella De Maria
Comparative Oncology Center, Institute for Cancer Research and Treatment, University of Torino, SP 142, Km 3 95, 10060 Candiolo Torino Italy
Oncogene 21:1785-90. 2002....
MET overexpression turns human primary osteoblasts into osteosarcomasSalvatore Patanè
Laboratory of Cancer Genetics, University of Turin School of Medicine, Candiolo Turin, Italy
Cancer Res 66:4750-7. 2006..These data show that MET overexpression is oncogenic and that it is essential for the maintenance of the cancer phenotype...
p38 MAPK turns hepatocyte growth factor to a death signal that commits ovarian cancer cells to chemotherapy-induced apoptosisNadia Coltella
Laboratory of Cancer Genetics, Institute for Cancer Research and Treatment, University of Turin Medical School, Candiolo, Italy
Int J Cancer 118:2981-90. 2006..Therefore, the p38 MAPK pathway might be a suitable target to improve response to conventional chemotherapy in human ovarian cancer...
Beta4 integrin is a transforming molecule that unleashes Met tyrosine kinase tumorigenesisAndrea Bertotti
Division of Molecular Oncology, Institute for Cancer Research and Treatment (IRCC, University of Torino School of Medicine, Candiolo (Torino, Italy
Cancer Res 65:10674-9. 2005....
Cancer: the matrix is now in controlPaolo M Comoglio
Nat Med 11:1156-9. 2005
Hepatocyte growth factor sensitizes human ovarian carcinoma cell lines to paclitaxel and cisplatinAndrea Rasola
Division of Molecular Oncology, Institute for Cancer Research and Treatment, University of Torino Medical School, Candiolo, Italy
Cancer Res 64:1744-50. 2004..This suggests that HGF may be used to improve response to chemotherapy in a set of human ovarian carcinomas molecularly classified based on the MET oncogene expression...
Beta4 integrin activates a Shp2-Src signaling pathway that sustains HGF-induced anchorage-independent growthAndrea Bertotti
Division of Molecular Oncology, Institute for Cancer Research and Treatment, University of Torino School of Medicine, 10060 Candiolo, Torino, Italy
J Cell Biol 175:993-1003. 2006..These results unravel a novel pathway whereby beta4 directs tyrosine kinase-based signals toward adhesion-unrelated outcomes...
